Boosting Trial Success Through Blinded Data Analytics: What Can We Learn From CNS? Date Published: Aug 17, 2020 Article This Journal of Clinical Studies article discusses the potential problems with subjective CNS data. Learn why the below causes data issues that can undermine a study: Traditional outcome scoring Paper-based assessments Manual calculations Insufficient rater training & monitoring Readers will learn how Signant solves these issues with advanced solutions, such as electronic Clinician Outcome Assessments (eCOA) and Blinded Data Analytics to services like Rater Training. To obtain reliable endpoints, sponsors should proactively address potential data problems. Download Now Share: LinkedInTweet Recommended Resources Article Innovations in Clinical Neuroscience: Articles on Pediatric and Orphan Disease Clinical Research Dr. Joan Busner, Signant’s Clinical Vice President and in-house expert on pediatric and orphan disease clinical trials, recently co-authored three... Download Now Article Cariprazine Found to be Effective Adjunctive Treatment for Major Depressive Disorder Treating major depressive disorder can be challenging since many patients do not respond to initial antidepressant treatment, leading to continued... Read the Article Article eCOA and the DCT Slope of Enlightenment Decentralized clinical trials (DCT) have become widely accepted in recent years. The life sciences industry is traditionally risk-averse when it... Download Now